DPP-4 inhibitors-renoprotection in diabetic nephropathy?
Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia usha.panchapakesan@sydney.edu.au.
Usha
U
Panchapakesan
Renal Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St. Leonards, New South Wales, Australia.
Carol A
CA
Pollock
D000818:Animals; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000494:pharmacology*; D042783:Endothelial Cells / Q000187:drug effects*; D000069476:Linagliptin; D008297:Male; D059630:Mesenchymal Stem Cells / Q000187:drug effects*; D011687:Purines / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D011687:Purines; D011799:Quinazolines; D000069476:Linagliptin